Assignee
AFFIMED GMBH
DE·11 granted patents·10 pending applications·33 citations·filing 2015–2024
Top patents by PatentIndex Score
21 records- 0189US9701750B2Anti-CD16 binding moleculesAFFIMED GMBH·Filed 2015·Granted Jul 11, 2017·11 cites·16 claims
- 0287US11535672B2Combination of an anti-CD16A antibody with a cytokineAFFIMED GMBH·Filed 2019·Granted Dec 27, 2022·8 cites·28 claims
- 0385US10066015B2CD3 binding domainsAFFIMED GMBH·Filed 2015·Granted Sep 4, 2018·10 cites·11 claims
- 0482US11510972B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2020·Granted Nov 29, 2022·1 cites·16 claims
- 0579US11001633B2NK cell engaging antibody fusion constructsAFFIMED GMBH·Filed 2019·Granted May 11, 2021·1 cites·14 claims
- 0678US2024294647A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2024·Application pending·0 cites
- 0774US10273309B2Antibody binding sites specific for EGFRvIIIAFFIMED GMBH·Filed 2016·Granted Apr 30, 2019·2 cites·21 claims
- 0873US12076384B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2022·Granted Sep 3, 2024·0 cites·17 claims
- 0966US2021253698A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 1065US12264198B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2021·Granted Apr 1, 2025·0 cites·11 claims
- 1160US11180558B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2019·Granted Nov 23, 2021·0 cites·11 claims
- 1258US2024376208A1DuplexbodiesAFFIMED GMBH·Filed 2022·Application pending·0 cites
- 1356US2015225484A1Antigen-binding molecule and uses thereofAFFIMED GMBH·Filed 2015·Application pending·0 cites
- 1456US2022340674A1Method for the production of bispecific fcyriii x cd30 antibody constructAFFIMED GMBH·Filed 2022·Application pending·0 cites
- 1553US2026070986A1Bispecific cd16a bindersAFFIMED GMBH·Filed 2022·Application pending·0 cites
- 1653US2023365709A1Trispecific bindersAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 1753US2024417475A1Bispecific cd16a bindersAFFIMED GMBH·Filed 2022·Application pending·0 cites
- 1852US2021169936A1Cryopreserved NK cells preloaded with an antibody constructAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 1944US11572415B2Multivalent FV antibodiesAFFIMED GMBH·Filed 2018·Granted Feb 7, 2023·0 cites·25 claims
- 2042US2017037128A1Trifunctional antigen-binding moleculeAFFIMED GMBH·Filed 2016·Application pending·0 cites
- 2141US11167029B2Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapyAFFIMED GMBH·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when AFFIMED GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →